Introduction
Residual viral replication and HIV-1 latency among individuals under antiretroviral therapy are the two major obstacles towards reduction of chronic micro-inflammation triggered by HIV and the success of sterilizing cure. A number of laboratory methods have been used for detection, quantification and understanding of residual viral replication.
Conclusions
CD4, CD8 counts, and raltegravir based regimens relate to decreased residual viral replication as inferred by epissomal DNA. The relationship between episomal DNA and total DNA suggests replenishment of proviral reservoir with potential impact on HIV persistence. Lower antibodies levels among patients with PI based initial treatment may suggest a more effective HIV suppression of these regimens, with higher capacity of decreasing the HIV antigenic component. 
